Merck & Company news
ΓMerck & Company
26.10.23
Merck & Company
Merck & Company's GAAP net income for 9 months of 2023 amounted to $1.603 billion, down 7.2 times from $11.508 billion in the previous year. Revenue increased 0.1% to $45.485 billion from $45.453 billion a year earlier.
Merck & Company's GAAP net income for 9 months of 2023 amounted to $1.603 billion, down 7.2 times from $11.508 billion in the previous year. Revenue increased 0.1% to $45.485 billion from $45.453 billion a year earlier.
Source: 
merck.com
merck.com
0
0
01.08.23
Merck & Company
Merck & Company's GAAP loss for 6 months of 2023 was $3.147 billion, against a profit of $8.256 billion in the prior year. Revenue declined 3.2% to $29.522 billion against $30.494 billion a year earlier.
Merck & Company's GAAP loss for 6 months of 2023 was $3.147 billion, against a profit of $8.256 billion in the prior year. Revenue declined 3.2% to $29.522 billion against $30.494 billion a year earlier.
Source: merck.com
merck.com
0
0
02.02.23
Merck & Company
Merck & Company's GAAP net income for 2022 was $14.519 billion, up 11.3% from $13.049 billion the previous year. Revenue rose 21.7% to $59.283 billion from $48.704 billion a year earlier.
Merck & Company's GAAP net income for 2022 was $14.519 billion, up 11.3% from $13.049 billion the previous year. Revenue rose 21.7% to $59.283 billion from $48.704 billion a year earlier.
Source: merck.com
merck.com
0
0
24.01.23
Merck & Company
The Merck & Company Board of Directors announced a quarterly dividend of $0.73 per share. The last day to buy securities to receive the dividend is March 13, 2023. The annual dividend yield may reach 2.94%.
The Merck & Company Board of Directors announced a quarterly dividend of $0.73 per share. The last day to buy securities to receive the dividend is March 13, 2023. The annual dividend yield may reach 2.94%.
Source: merck.com
merck.com
0
0
27.10.22
Merck & Company
Merck & Company's GAAP net income for 9 months of 2022 was $11.502 billion, up 23.8% from $9.291 billion in the previous year. Revenue increased 29.2% to $45.453 billion from $35.183 billion a year earlier.
Merck & Company's GAAP net income for 9 months of 2022 was $11.502 billion, up 23.8% from $9.291 billion in the previous year. Revenue increased 29.2% to $45.453 billion from $35.183 billion a year earlier.
Source: merck.com
merck.com
0
0
27.07.22
Merck & Company
Merck&Company Board of Directors announced a quarterly dividend of $0.69 per share. The last day to buy securities to receive the dividend is September 13, 2022. The annual dividend yield may reach 3.39%.
Merck&Company Board of Directors announced a quarterly dividend of $0.69 per share. The last day to buy securities to receive the dividend is September 13, 2022. The annual dividend yield may reach 3.39%.
Source: merck.com
merck.com
0
0
07.07.22
Merck & Company
Merck & Co. is in talks to buy Seagen, a biotech company that develops drugs to treat cancer, sources told the Wall Street Journal. Merck & Co. could pay about $40 billion, or more than $200 per Seagen share. The companies plan to close the deal before Merck announces its Q2 2022 financial results, due July 28.
Merck & Co. is in talks to buy Seagen, a biotech company that develops drugs to treat cancer, sources told the Wall Street Journal. Merck & Co. could pay about $40 billion, or more than $200 per Seagen share. The companies plan to close the deal before Merck announces its Q2 2022 financial results, due July 28.
Source: 
reuters.com
reuters.com
0
0
20.06.22
Merck & Company
Merck & Co. is in talks to buy biotech company Seagen, sources told the Wall Street Journal. The company specializes in the development of innovative cancer treatments. The result of the negotiations could be both the purchase of the company and the conclusion of a marketing agreement.
Merck & Co. is in talks to buy biotech company Seagen, sources told the Wall Street Journal. The company specializes in the development of innovative cancer treatments. The result of the negotiations could be both the purchase of the company and the conclusion of a marketing agreement.
Source: reuters.com
reuters.com
0
0
25.05.22
Merck & Company
The Merck & Company Board of Directors announced a quarterly dividend of $0.69 per share. The last day to buy securities to receive the dividend is June 13, 2022. The annual dividend yield may reach 3.44%.
The Merck & Company Board of Directors announced a quarterly dividend of $0.69 per share. The last day to buy securities to receive the dividend is June 13, 2022. The annual dividend yield may reach 3.44%.
Source: merck.com
merck.com
0
0
28.04.22
Merck & Company
Merck & Company's GAAP net income for 3 months of 2022 was $1.7 million, up 34.9% from $1.26 million in the previous year. Revenue increased 49.6% to $15.901 billion from $10.627 billion a year earlier.
Merck & Company's GAAP net income for 3 months of 2022 was $1.7 million, up 34.9% from $1.26 million in the previous year. Revenue increased 49.6% to $15.901 billion from $10.627 billion a year earlier.
Source: merck.com
merck.com
0
0
English (US) 